Safety Profile of New Therapies

Video content above is prompted by the following:

• Based on the clinical trial data, how do you view the safety profiles of faricimab and aflibercept 8 mg?
• Does the long-term safety profile of aflibercept 2 mg increase your confidence in the safety of aflibercept 8 mg?
• Does the increased volume of aflibercept 8 mg raise concerns about the potential for elevated intraocular pressure? How do you evaluate and address this in clinical practice?